Polyarteritis nodosa: Difference between revisions

(Add verified PubMed references (PMIDs 24485157, 38068989))
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
==Background==
==Background==
*Necrotizing [[vasculitis]] of small- and medium-sized blood vessels
*Necrotizing [[vasculitis]] of small- and medium-sized blood vessels<ref>Hernández-Rodríguez J, et al. Diagnosis and classification of polyarteritis nodosa. J Autoimmun. 2014 Feb-Mar;48-49:84-9. PMID 24485157</ref>
*Skin, musculoskeletal, CNS, and GI tract (spares lung)
*Skin, musculoskeletal, CNS, and GI tract (spares lung)
*Predilection to arterial bifurcations and branch sites
*Predilection to arterial bifurcations and branch sites<ref>Wolff L, et al. Polyarteritis Nodosa: Old Disease, New Etiologies. Int J Mol Sci. 2023 Nov 23;24(23). PMID 38068989</ref>
*Microaneurysm, [[thromboembolism|thrombosis, emboli]], organ ischemia, and infarction
*Microaneurysm, [[thromboembolism|thrombosis, emboli]], organ ischemia, and infarction
*Etiology: Idiopathic, [[HBV]], [[hepatitis C|HCV]], hairy cell [[leukemia]]
*Etiology: Idiopathic, [[HBV]], [[hepatitis C|HCV]], hairy cell [[leukemia]]
{{Primary Vasculitis DDX}}


==Clinical Features==
==Clinical Features==
Line 26: Line 28:
==Differential Diagnosis==
==Differential Diagnosis==
*Embolism, thrombosis, atherosclerosis
*Embolism, thrombosis, atherosclerosis
*[[HIV]], [[Hepatitis]], IE, mycotic aneurysm
*[[HIV]], [[Hepatitis]], IE, [[mycotic aneurysm]]
*Fibromuscular dysplasia
*Fibromuscular dysplasia
*Microscopic polyangiitis, [[Granulomatosis with polyangiitis]] (Wegener's), [[Eosinophilic granulomatosis with polyangiitis]] (Churg-Strauss), IgA vasculitis, drug-induced vasculitis, [[connective tissue disease]], [[SLE]], cryoglobulinemic vasculitis
*Microscopic polyangiitis, [[Granulomatosis with polyangiitis]] (Wegener's), [[Eosinophilic granulomatosis with polyangiitis]] (Churg-Strauss), IgA vasculitis, drug-induced vasculitis, [[connective tissue disease]], [[SLE]], cryoglobulinemic vasculitis

Latest revision as of 10:55, 22 March 2026

Background

  • Necrotizing vasculitis of small- and medium-sized blood vessels[1]
  • Skin, musculoskeletal, CNS, and GI tract (spares lung)
  • Predilection to arterial bifurcations and branch sites[2]
  • Microaneurysm, thrombosis, emboli, organ ischemia, and infarction
  • Etiology: Idiopathic, HBV, HCV, hairy cell leukemia

Vasculitis Syndrome Types

Clinical Features

Cutaneous polyarteritis nodosa. (A) The patient presented with livedo reticularis on the lower legs. (B) Vasculitis involves the muscular artery of the deep dermis.
  • Cutaneous lesion + adult onset hypertension
  • Men > women (2:1)
  • Peak age 40-60s
  • Systemic: Fatigue, weight loss, weakness, fever, arthralgia
  • Cutaneous lesions (1/3 patients)
    • Tender erythematous nodules
    • Palpable purpura (fingers, ankles, malleoli, pretibial)
    • Digital cyanosis
    • Splinter hemorrhages
    • Livedo reticularis
  • Renovascular arteritis → hypertension
  • Peripheral neuropathies (mononeuritis multiplex, polyneuropathy)
  • Mesenteric vasculitis (abdominal angina, ischemia, infarction, perforation)
  • Myocardial ischemia and heart failure
  • Myalgia (elevated CK)

Differential Diagnosis

Evaluation

Workup

Diagnosis

American College of Rheumatology Criteria

Need at least 3/10 (82% sensitivity and 87% specificity)

  • Unexplained weight loss greater than 4kg
  • Livedo reticularis
  • Testicular Pain or tenderness
  • Myalgia (excluding shoulder and hip girdle), weakness of muscles, tenderness of leg muscles, or polyneuropathy
  • Mononeuropathy or polyneuropathy
  • New-onset diastolic blood pressure > 90mmHg
  • Elevated serum BUN (>40mg/dL or 14.3mmol/L) or creatinine (>1.5mg/dL or 132 mmol/L)
  • Evidence of HBV infection (serology)
  • Characteristic arteriographic abnormalities not resulting fro noninflammatory disease processes
  • Biopsy of small- or medium-sized artery containing polymorphonuclear cells

Management

References

  1. Hernández-Rodríguez J, et al. Diagnosis and classification of polyarteritis nodosa. J Autoimmun. 2014 Feb-Mar;48-49:84-9. PMID 24485157
  2. Wolff L, et al. Polyarteritis Nodosa: Old Disease, New Etiologies. Int J Mol Sci. 2023 Nov 23;24(23). PMID 38068989
  • Reference: Rosen's Emergency Medicine 8th edition. 2013. Chapter: Erythematosus and the Vasculitides. p1539-1540.
  • Merkel PA, et al. Clinical manifestations and diagnosis of polyarteritis nodosa in adults. In: Post T, ed. UpToDate. Waltham, Mass.: UpToDate; 2014. www.uptodate.com. Accessed December 22, 2014.
  • Merkel PA, et al. Treatment and prognosis of polyarteritis nodosa. In: Post T, ed. UpToDate. Waltham, Mass.: UpToDate; 2014. www.uptodate.com. Accessed December 22, 2014.
  • Jacobs-Kosmin, D. (2014, Dec 12). Polyarteritis Nodosa. eMedicine. Retrieved 12/22/2014 from http://emedicine.medscape.com/article/330717-overview.